Fairvalue-Calculator Fairvalue-Calculator
EN DE

Dahu Health Industry Co (600257) Fair Value & Analysis

Consumer Defensive · CN · Market cap 2.4B CNY

Price¥4.71
Fair Value¥1.29
Upside-72.6%
Quality80/100
Evidence: Medium Range ¥0.6100 – ¥1.96

Fair value as of: Jun 24, 2026

Analysis

Dahu Health Industry Co (600257) currently trades at ¥4.71, while our model-based Fair Value estimate is ¥1.29 — implying the stock looks roughly 72.6% overvalued today. We read business quality at 80/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Dahu Health Industry Co., Ltd., together with its subsidiaries, engages in the aquatic products, wine and spirits, healthcare, and other businesses primarily in China. It offers chilled and frozen aquatic products; and wine products. In addition, the company sells pearl jewelry and health products. Further, it offers patient care, rehabilitation, and nursing services, including neurological, bone and joint, geriatric, cardiopulmonary, pediatric rehabilitation, basic living care, and end-of-life care. The company was formerly known as Dahu Aquaculture Co., Ltd. and changed its name to Dahu Health Industry Co., Ltd. in October 2025. Dahu Health Industry Co., Ltd. was founded in 1999 and is based in Changde, China.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Dahu Health Industry Co (600257) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥1.29 versus a price of ¥4.71 — about −73% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 600257?
Our 21-model fair value for Dahu Health Industry Co is ¥1.29 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥4.71.
What is the quality score of 600257?
Dahu Health Industry Co has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.